Endologix, Inc. (ELGX) Misses Q4 EPS by 1c; Guides FY12 EPS, Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Loss from operations: -11.23M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Loss from operations: -11.23M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Endologix, Inc. (NASDAQ: ELGX) reported Q4 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $23.4 million versus the consensus estimate of $23.67 million.
Endologix, Inc. sees FY2012 EPS of $-0.12-$-0.18, versus the consensus of $-0.07. Endologix, Inc. sees FY2012 revenue of $102-$107 million, versus the consensus of $106.3 million.
For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.
Endologix, Inc. sees FY2012 EPS of $-0.12-$-0.18, versus the consensus of $-0.07. Endologix, Inc. sees FY2012 revenue of $102-$107 million, versus the consensus of $106.3 million.
For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- RBC Capital Reiterates Outperform Rating on Verisk Analytics (VRSK)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
